Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
about
Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson's Disease.Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B.An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.
P2860
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@ast
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@en
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@nl
type
label
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@ast
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@en
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@nl
prefLabel
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@ast
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@en
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@nl
P2093
P2860
P1476
Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
@en
P2093
Benshu Zhang
Shishuang Zhang
Xiaodong Kong
P2860
P407
P577
2015-01-01T00:00:00Z